{"name": "Pacgen Biopharmaceuticals",
 "permalink": "pacgen-biopharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/pacgen-biopharmaceuticals",
 "homepage_url": "http://www.pacgenbiopharm.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pacgenbiopharm.com",
 "phone_number": "1 (604) 436-4388",
 "description": "development of drugs",
 "created_at": "Fri Sep 04 13:23:30 UTC 2009",
 "updated_at": "Fri Sep 04 13:25:29 UTC 2009",
 "overview": "\u003Cp\u003EPacgen Biopharmaceuticals Corporation, a life sciences company, focuses on the development of novel therapeutic drugs for the treatment of infectious and inflammatory diseases in Canada. The company\u00e2\u20ac\u2122s lead products include PAC-113, an anti-fungal agent, which has completed a Phase IIb clinical program for the treatment of oral Candidiasis. Its early stage research program includes a peptide therapeutic, PAC-G31P, which is in preclinical studies for its potential to treat inflammatory diseases, such as ARDS, pneumonia, asthma, and chronic obstructive pulmonary disease. The company was founded in 2004 and is headquartered in Vancouver, Canada.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       25],
      "assets/images/resized/0005/8744/58744v1-max-150x150.jpg"],
     [[250,
       42],
      "assets/images/resized/0005/8744/58744v1-max-250x250.jpg"],
     [[339,
       58],
      "assets/images/resized/0005/8744/58744v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 310000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "http://www.tradingmarkets.com/.site/news/Stock%20News/2480679/",
    "source_description": "Pacgen Biopharmaceuticals acquires Xphase Pharmaceuticals",
    "acquired_year": 2009,
    "acquired_month": 8,
    "acquired_day": 13,
    "company":
     {"name": "Xphase Pharmaceuticals",
      "permalink": "xphase-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            90],
           "assets/images/resized/0005/8746/58746v1-max-150x150.jpg"],
          [[162,
            98],
           "assets/images/resized/0005/8746/58746v1-max-250x250.jpg"],
          [[162,
            98],
           "assets/images/resized/0005/8746/58746v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "HQ",
    "address1": "505 Burrard Street",
    "address2": "Suite 1730",
    "zip_code": "V7X 1M6",
    "city": "Vancouver",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        137],
       "assets/images/resized/0005/8745/58745v1-max-150x150.jpg"],
      [[250,
        228],
       "assets/images/resized/0005/8745/58745v1-max-250x250.jpg"],
      [[450,
        411],
       "assets/images/resized/0005/8745/58745v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}